| Literature DB >> 31817482 |
Sophia Morel1,2, Devendra Amre3, Emma Teasdale1, Maxime Caru4, Caroline Laverdière3, Maja Krajinovic3, Daniel Sinnett3, Daniel Curnier4, Emile Levy1,2, Valérie Marcil1,2.
Abstract
Survivors of childhood acute lymphoblastic leukemia (cALL) are at high risk of developing dyslipidemia, including low HDL-cholesterol (HDL-C). This study aimed to examine the associations between food/nutrient intake and the levels of HDL-C in a cohort of children and young adult survivors of cALL. Eligible participants (n = 241) were survivors of cALL (49.4% boys; median age: 21.7 years old) recruited as part of the PETALE study. Nutritional data were collected using a validated food frequency questionnaire. Fasting blood was used to determine participants' lipid profile. Multivariable logistic regression models were fitted to evaluate the associations between intakes of macro- and micronutrients and food groups and plasma lipids. We found that 41.3% of cALL survivors had at least one abnormal lipid value. Specifically, 12.2% had high triglycerides, 17.4% high LDL-cholesterol, and 23.1% low HDL-C. Low HDL-C was inversely associated with high intake (third vs. first tertile) of several nutrients: proteins (OR: 0.27, 95% CI: 0.08-0.92), zinc (OR: 0.26, 95% CI: 0.08-0.84), copper (OR: 0.34, 95% CI: 0.12-0.99), selenium (OR: 0.17, 95% CI: 0.05-0.59), niacin (OR: 0.25, 95% CI: 0.08-0.84), riboflavin (OR: 0.31, 95% CI: 0.12-0.76) and vitamin B12 (OR: 0.35, 95% CI: 0.13-0.90). High meat consumption was also inversely associated (OR: 0.28, 95% CI: 0.09-0.83) with low HDL-C while fast food was positively associated (OR: 2.41, 95% CI: 1.03-5.63) with low HDL-C. The role of nutrition in the development of dyslipidemia after cancer treatment needs further investigation.Entities:
Keywords: HDL-cholesterol; adolescent; childhood leukemia survivor; nutrition; young adults
Mesh:
Substances:
Year: 2019 PMID: 31817482 PMCID: PMC6950746 DOI: 10.3390/nu11122977
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 5.717
Demographic and clinical characteristics of participants.
| Total | Adults | Children | |
|---|---|---|---|
| Median (range or interquartile range 1) | |||
| Age at visit, years (range) | 21.3 (8.5–40.9) | 24.6 (18.0–40.9) | 16.2 (8.5–17.9) |
| Age at cancer diagnosis, years (range) | 4.7 (0.9–18.0) | 6.5 (0.9–18.0) | 3.5 (1.3–10.9) |
| Time since end of treatment, years (range) | 12.9 (3.3–26.1) | 16.11 (3.9–26.1) | 9.60 (3.3–13.4) |
| Gender (male, %) | 49.4 | 57.3 | 49.4 |
| ALL types 2 | |||
| Pre-B ALL ( | 208 (88.5) | 128 (84.8) | 80 (95.2) |
| Pre-T ALL ( | 27 (11.5) | 23 (15.2) | 4 (4.8) |
| ALL subtypes 3 | |||
| Hyperdiploidy ( | 33 (21.6) | 18 (19.8) | 15 (24.2) |
| Pre-B or Pre-T with recurrent genetic abnormalities ( | 52 (34.0) | 28 (30.8) | 24 (38.7) |
| Hypodiploidy ( | 4 (2.6) | 3 (3.3) | 1 (1.6) |
| Others (NOS) ( | 64 (41.8) | 42 (46.1) | 22 (35.5) |
| Metabolic data | |||
| Physical activity 4 (min/day) | 20.6 (7.6–39.5) | 15.7 (3.95–36.6) | 28.9 (14.1–46.5) |
| Estimated energy requirement (kcal) | 2328 (2011–2721) | 2373 (2039–2707) | 2224 (1964–2834) |
| Energy balance (kcal) | 142 (−213–649) | 133 (−224–644) | 148 (−172–679) |
| BMI (kg/m2) | 23.5 (20.9–26.1) | 24.3 (21.7–27.4) | 21.8 (19.2–24.1) |
| Waist-to-height ratio | 0.50 (0.46–0.55) | 0.51 (0.48–0.58) | 0.49 (0.45–0.52) |
| Glucose (mmol/L) | 5.0 (4.8–5.3) | 5.0 (4.8–5.4) | 5.0 (4.8–5.3) |
| Insulin (pmol/L) | 53.3 (37.6–75.8) | 50.1 (35.2–68.6) | 58.1 (42.9–81.1) |
| HOMA-IR | 1.7 (1.2–2.5) | 1.7 (1.1–2.3) | 1.9 (1.3–2.7) |
| Total cholesterol (mmol/L) | 4.37 (3.87–5.01) | 4.59 (4.10–5.15) | 4.18 (3.61–4.63) |
| Triglyceride (mmol/L) | 0.91 (0.66–1.25) | 0.97 (0.72–1.38) | 0.82 (0.62–1.07) |
| LDL-C (mmol/L) | 2.57 (2.13–3.16) | 2.73 (2.22–3.32) | 2.36 (2.04–2.82) |
| HDL-C (mmol/L) | 1.30 (1.12–1.49) | 1.31 (1.13–1.52) | 1.29 (1.09–1.45) |
1 Interquartile range: 25th and 75th percentiles. 2 ALL types were not available for six participants. 3 ALL subtypes were not available for 88 participants out of 241. 4 Daily minutes of moderate-to-vigorous leisure physical activities. ALL, acute lymphoblastic leukemia; NOS, not otherwise specified; BMI, body mass index; HOMA-IR, homeostasis model assessment-insulin resistance; LDL-C, low-density lipoprotein-cholesterol; HDL-C, high-density lipoprotein-cholesterol.
Participants’ intake of energy, macro- and micronutrients.
| Total | Tertile 1 | Tertile 2 | Tertile 3 | |
|---|---|---|---|---|
| Median (interquartile range 1) | ||||
| Energy intake (kcal) | 2512 (2143–3077) | 1897 | 2511 | 3398 |
| Macronutrients | ||||
| Proteins (g) | 109 (87.3–131) | 80.4 | 108.9 | 144.0 |
| Carbohydrates (g) | 318 (267–391) | 247.8 | 317.9 | 426.4 |
| Dietary fibers (g) | 23.8 (19.0–29.6) | 16.6 | 24.0 | 33.4 |
| Lipids (g) | 90.2 (71.6–114.8) | 63.0 | 90.2 | 123.1 |
| Omega-6 (g) | 4.4 (3.1–6.5) | 2.6 | 4.4 | 7.9 |
| Omega-3 (g) | 0.8 (0.6–1.4) | 0.5 | 0.8 | 1.8 |
| Ratio ω-6/ω-3 | 5.3 (4.0–6.9) | 3.6 | 5.4 | 7.5 |
| Micronutrients | ||||
| Calcium (mg) | 1349 (1047–1782) | 931 | 1349 | 1993 |
| Iron (mg) | 16.3 (13.6–21.5) | 12.7 | 16.3 | 23.5 |
| Magnesium (mg) | 405 (342–497) | 311 | 406 | 547 |
| Phosphorus (mg) | 1810 (1452–2192) | 1351 | 1810 | 2445 |
| Potassium (mg) | 3975 (3337–4763) | 3028 | 3975 | 5202 |
| Sodium (mg) | 3428 (2673–4522) | 2372 | 3428 | 4996 |
| Zinc (mg) | 15.6 (12.4–19.5) | 11.6 | 15.6 | 21.2 |
| Copper (mg) | 1.9 (1.5–2.3) | 1.4 | 1.8 | 2.4 |
| Manganese (mg) | 4.1 (3.2–5.2) | 2.8 | 4.1 | 5.8 |
| Selenium (mcg) | 139 (112–176) | 102 | 139 | 192 |
| Retinol (mcg) | 469 (330–681) | 286 | 469 | 744 |
| Folic acid (mcg) | 628 (505–781) | 445 | 627 | 871 |
| Niacin (mg) | 26.5 (21.0–33.6) | 19.0 | 26.2 | 35.9 |
| Riboflavin (mg) | 2.8 (2.3–3.5) | 2.1 | 2.8 | 3.8 |
| Thiamine (mg) | 2.2 (1.8–2.8) | 1.5 | 2.2 | 3.0 |
| Vitamin B6 (mg) | 2.4 (1.9–2.9) | 1.7 | 2.3 | 3.1 |
| Vitamin B12 (mcg) | 5.7 (4.3–7.7) | 3.8 | 5.7 | 8.6 |
| Choline (mg) | 283 (224–355) | 201 | 283 | 389 |
| Vitamin C (mg) | 210 (136–275) | 114 | 210 | 319 |
| Vitamin D (mcg) | 5.6 (4.1–8.4) | 3.5 | 5.6 | 9.80 |
| Vitamin K (mcg) | 122 (87.4–170) | 74.1 | 122 | 204 |
| Food groups | ||||
| Meat | 1.8 (1.3–2.6) | 1.0 | 1.8 | 3.0 |
| Fish and seafood | 0.3 (0.1–0.5) | 0.03 | 0.3 | 0.7 |
| Dairy | 3.2 (2.1–4.7) | 1.6 | 3.2 | 5.0 |
| Fat | 1.5 (1.0–2.4) | 0.7 | 1.5 | 3.1 |
| Vegetables | 3.1 (2.0–4.5) | 1.5 | 3.1 | 5.1 |
| Legumes | 0.03 (0.0–0.1) | 0.0 | 0.03 | 0.2 |
| Fruits | 1.9 (1.2–3.1) | 0.9 | 1.9 | 3.6 |
1 Interquartile range: 25th and 75th percentiles. ω, omega; g, grams; mg, milligrams; mcg, micrograms.
Figure 1Intakes in proteins, minerals and vitamins of cALL survivors expressed as percentage of RDA (y axis) for each participant (x axis). (a) Proteins; (b) Selenium; (c) Copper; (d) Zinc; (e) Phosphorus; (f) Riboflavin; (g) Niacin. HDL-C, high density lipoprotein-cholesterol; RDA, recommended dietary allowance. Blue rectangle = Normal HDL; red diamond = Low HDL-C.
Association between macronutrient intake and low HDL-C in cALL survivors.
| Macronutrients | Odds Ratio | 95% CI | |
|---|---|---|---|
| Proteins | |||
| Tertile 2 vs. Tertile 1 | 0.300 | 0.12–0.74 | 0.009 |
| Tertile 3 vs. Tertile 1 | 0.289 | 0.08–1.00 | 0.05 |
| Carbohydrates | |||
| Tertile 2 vs. Tertile 1 | 0.705 | 0.29–1.70 | 0.436 |
| Tertile 3 vs. Tertile 1 | 0.612 | 0.17–2.19 | 0.450 |
| Fats | |||
| Tertile 2 vs. Tertile 1 | 0.723 | 0.30–1.74 | 0.468 |
| Tertile 3 vs. Tertile 1 | 0.876 | 0.26–2.91 | 0.829 |
| Fibers | |||
| Tertile 2 vs. Tertile 1 | 0.914 | 0.41–2.02 | 0.824 |
| Tertile 3 vs. Tertile 1 | 0.603 | 0.23–1.59 | 0.308 |
| Omega-3 | |||
| Tertile 2 vs. Tertile 1 | 1.347 | 0.59–3.05 | 0.475 |
| Tertile 3 vs. Tertile 1 | 1.002 | 0.40–2.53 | 0.995 |
| Omega-6 | |||
| Tertile 2 vs. Tertile 1 | 0.897 | 0.39–2.10 | 0.800 |
| Tertile 3 vs. Tertile 1 | 0.652 | 0.26–1.61 | 0.354 |
| Ratio omega-3: omega-6 | |||
| Tertile 2 vs. Tertile 1 | 1.087 | 0.48–2.44 | 0.840 |
| Tertile 3 vs. Tertile 1 | 1.385 | 0.62–3.09 | 0.426 |
HDL-C, high-density lipoprotein-cholesterol; cALL: childhood acute lymphoblastic leukemia; CI, confidence interval. Multivariable logistic regression model adjusted for BMI (kg/m2), age at diagnosis (years), age at diagnosis squared (years), sex (female), total energy intake (kcal) and moderate-to-vigorous physical activity (minutes per day).
Association between mineral intake and low HDL-C in cALL survivors.
| Minerals | Odds Ratio | 95% CI | |
|---|---|---|---|
| Calcium | |||
| Tertile 2 vs. Tertile 1 | 0.774 | 0.33–1.80 | 0.553 |
| Tertile 3 vs. Tertile 1 | 0.830 | 0.31–2.22 | 0.711 |
| Magnesium | |||
| Tertile 2 vs. Tertile 1 | 0.624 | 0.27–1.42 | 0.262 |
| Tertile 3 vs. Tertile 1 | 0.350 | 0.11–1.12 | 0.078 |
| Phosphorus | |||
| Tertile 2 vs. Tertile 1 | 0.362 | 0.15–0.88 | 0.024 |
| Tertile 3 vs. Tertile 1 | 0.333 | 0.10–1.13 | 0.077 |
| Potassium | |||
| Tertile 2 vs. Tertile 1 | 0.754 | 0.32–1.79 | 0.523 |
| Tertile 3 vs. Tertile 1 | 0.692 | 0.22–2.18 | 0.528 |
| Sodium | |||
| Tertile 2 vs. Tertile 1 | 0.382 | 0.15–0.97 | 0.044 |
| Tertile 3 vs. Tertile 1 | 1.134 | 0.35–3.65 | 0.832 |
| Iron | |||
| Tertile 2 vs. Tertile 1 | 0.478 | 0.21–1.11 | 0.086 |
| Tertile 3 vs. Tertile 1 | 0.395 | 0.12–1.27 | 0.118 |
| Zinc | |||
| Tertile 2 vs. Tertile 1 | 0.311 | 0.13–0.76 | 0.010 |
| Tertile 3 vs. Tertile 1 | 0.257 | 0.08–0.84 | 0.025 |
| Copper | |||
| Tertile 2 vs. Tertile 1 | 0.32 | 0.13–0.76 | 0.009 |
| Tertile 3 vs. Tertile 1 | 0.27 | 0.09–0.81 | 0.020 |
| Manganese | |||
| Tertile 2 vs. Tertile 1 | 0.616 | 0.27–1.39 | 0.243 |
| Tertile 3 vs. Tertile 1 | 0.639 | 0.25–1.60 | 0.340 |
| Selenium | |||
| Tertile 2 vs. Tertile 1 | 0.377 | 0.16–0.89 | 0.026 |
| Tertile 3 vs. Tertile 1 | 0.175 | 0.05–0.62 | 0.007 |
HDL-C, high-density lipoprotein cholesterol; cALL: childhood acute lymphoblastic leukemia; OR, odds ratio; CI, confidence interval. Multivariable logistic regression model adjusted for BMI (kg/m2), age at diagnosis (years), age at diagnosis squared (years), sex (female), total energy intake (kcal) and moderate-to-vigorous physical activity (minutes per day).
Association between vitamin intake and low HDL-C in cALL survivors.
| Vitamins | Odds Ratio | 95% CI | |
|---|---|---|---|
| Retinol | |||
| Tertile 2 vs. Tertile 1 | 0.639 | 0.28–1.47 | 0.291 |
| Tertile 3 vs. Tertile 1 | 0.609 | 0.24–1.56 | 0.301 |
| Alpha-carotene | |||
| Tertile 2 vs. Tertile 1 | 1.444 | 0.66–3.16 | 0.356 |
| Tertile 3 vs. Tertile 1 | 0.880 | 0.39–2.00 | 0.760 |
| Beta-carotene | |||
| Tertile 2 vs. Tertile 1 | 1.523 | 0.67–3.44 | 0.312 |
| Tertile 3 vs. Tertile 1 | 0.887 | 0.37–2.15 | 0.790 |
| Thiamin | |||
| Tertile 2 vs. Tertile 1 | 0.634 | 0.27–1.51 | 0.302 |
| Tertile 3 vs. Tertile 1 | 0.741 | 0.26–2.11 | 0.575 |
| Riboflavin | |||
| Tertile 2 vs. Tertile 1 | 0.300 | 0.12–0.74 | 0.009 |
| Tertile 3 vs. Tertile 1 | 0.248 | 0.07–0.86 | 0.028 |
| Niacin | |||
| Tertile 2 vs. Tertile 1 | 0.268 | 0.11–0.65 | 0.004 |
| Tertile 3 vs. Tertile 1 | 0.263 | 0.08–0.88 | 0.030 |
| Vitamin B6 | |||
| Tertile 2 vs. Tertile 1 | 0.871 | 0.38–2.01 | 0.747 |
| Tertile 3 vs. Tertile 1 | 0.395 | 0.12–1.27 | 0.119 |
| Choline | |||
| Tertile 2 vs. Tertile 1 | 0.480 | 0.20–1.16 | 0.104 |
| Tertile 3 vs. Tertile 1 | 0.518 | 0.18–1.50 | 0.225 |
| Folic acid | |||
| Tertile 2 vs. Tertile 1 | 0.624 | 0.26–1.47 | 0.281 |
| Tertile 3 vs. Tertile 1 | 0.571 | 0.20–1.66 | 0.304 |
| Vitamin B12 | |||
| Tertile 2 vs. Tertile 1 | 0.713 | 0.31–1.63 | 0.424 |
| Tertile 3 vs. Tertile 1 | 0.580 | 0.22–1.55 | 0.276 |
| Vitamine C | |||
| Tertile 2 vs. Tertile 1 | 0.850 | 0.37–1.93 | 0.698 |
| Tertile 3 vs. Tertile 1 | 0.864 | 0.36–2.07 | 0.744 |
| Vitamin D | |||
| Tertile 2 vs. Tertile 1 | 0.713 | 0.32–1.60 | 0.414 |
| Tertile 3 vs. Tertile 1 | 0.633 | 0.26–1.53 | 0.309 |
| Vitamin K | |||
| Tertile 2 vs. Tertile 1 | 1.181 | 0.51–2.71 | 0.695 |
| Tertile 3 vs. Tertile 1 | 0.988 | 0.41–2.40 | 0.978 |
HDL-C, high-density lipoprotein-cholesterol; cALL: childhood acute lymphoblastic leukemia; OR, odds ratio; CI, confidence interval. Multivariable logistic regression model adjusted for BMI (kg/m2), age at diagnosis (years), age at diagnosis squared (years), sex (female), total energy intake (kcal) and moderate-to-vigorous physical activity (minutes per day).
Association between intake of food groups and low HDL-C in cALL survivors.
| Food Groups | Odd Ratio | 95% CI | |
|---|---|---|---|
| Meat | |||
| Tertile 2 vs. Tertile 1 | 0.572 | 0.23–1.40 | 0.222 |
| Tertile 3 vs. Tertile 1 | 0.277 | 0.09–0.83 | 0.022 |
| Fish and seafood | |||
| Tertile 2 vs. Tertile 1 | 1.166 | 0.49–2.80 | 0.731 |
| Tertile 3 vs. Tertile 1 | 0.630 | 0.24–1.63 | 0.339 |
| Dairy | |||
| Tertile 2 vs. Tertile 1 | 0.886 | 0.36–2.18 | 0.792 |
| Tertile 3 vs. Tertile 1 | 1.155 | 0.43–3.09 | 0.775 |
| Fat | |||
| Tertile 2 vs. Tertile 1 | 1.179 | 0.48–2.92 | 0.722 |
| Tertile 3 vs. Tertile 1 | 1.581 | 0.57–4.39 | 0.379 |
| Vegetables | |||
| Tertile 2 vs. Tertile 1 | 1.165 | 0.44–3.07 | 0.757 |
| Tertile 3 vs. Tertile 1 | 1.282 | 0.46–3.54 | 0.632 |
| Legumes | |||
| Tertile 2 vs. Tertile 1 | 1.016 | 0.41–2.51 | 0.971 |
| Tertile 3 vs. Tertile 1 | 0.902 | 0.39–2.08 | 0.809 |
| Fruits | |||
| Tertile 2 vs. Tertile 1 | 0.261 | 0.10–0.70 | 0.008 |
| Tertile 3 vs. Tertile 1 | 0.920 | 0.38–2.24 | 0.854 |
| Fast food | |||
| Tertile 2 vs. Tertile 1 | 2.405 | 1.03–5.63 | 0.043 |
| Tertile 3 vs. Tertile 1 | 2.260 | 0.85–6.03 | 0.104 |
HDL-C, high-density lipoprotein cholesterol; cALL: childhood acute lymphoblastic leukemia; OR, odds ratio; CI, confidence interval. Multivariable logistic regression model adjusted for BMI (kg/m2), age at diagnosis (years), age at diagnosis squared (years), sex (female), total energy intake (kcal) and moderate-to-vigorous physical activity (minutes per day). Food groups were fitted into a single model except for fast food that was analyzed separately.
Figure 2Intakes in energy and macronutrients per 1000 kcal of cALL survivors with low and normal HDL-C. (a) Energy intake; (b) Proteins; (c) Carbohydrates; (d) Dietary fibers; (e) Lipids. Data are presented as median ± interquartile range.
Figure 3Intakes in micronutrients per 1000 kcal of cALL survivors with low and normal HDL-C. (a) Selenium; (b) Copper; (c) Zinc; (d) Phosphorus; (e) Riboflavin; (f) Niacin. * p < 0.05 versus ALL survivors with normal HDL-C. Data are presented as median ± interquartile range. ** p < 0.01 versus ALL survivors with normal HDL-C.
Figure 4Intakes in energy (kcal/kg bodyweight) and macronutrients (g/kg bodyweight) of cALL survivors with low and normal HDL-C. (a) Energy intake; (b) Proteins; (c) Carbohydrates; (d) Dietary fibers; (e) Lipids. Data are presented as median ± interquartile range. * p < 0.05 versus ALL survivors with normal HDL-C.
Figure 5Intakes in micronutrients (mg/kg bodyweight) of cALL survivors with low and normal HDL-C. (a) Selenium; (b) Copper; (c) Zinc; (d) Phosphorus; (e) Riboflavin; (f) Niacin. * p < 0.05 versus ALL survivors with normal HDL-C. Data are presented as median ± interquartile range. ** p < 0.01 versus ALL survivors with normal HDL-C.